Suppression of matrix metalloproteinase-2-mediated cell invasion in U87MG, human glioma cells by anti-microtubule agent: In vitro study

British Journal of Cancer

Volumn 77, Issue 1, 1998, Pages 21-25

  Yoshida, D ^a   Piepmeier, J M ^b   Bergenheim, T ^c   Henriksson, R ^c   Teramoto, A ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UMEÅ UNIVERSITY   (Sweden)

Author keywords

Estramustine; Glioblastoma; Matrigel; Matrix metalloproteinase; Tumour invasion

Indexed keywords

COLLAGEN; ESTRAMUSTINE; GELATINASE A;

ARTICLE; CELL INVASION; CELL PROLIFERATION; COLLAGEN DEGRADATION; ENZYME ACTIVITY; GLIOMA CELL; HUMAN; HUMAN CELL; MICROTUBULE; PRIORITY JOURNAL;

EID: 0031984665     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1998.4     Document Type: Article

References (40)

1. Abe T, Mori T, Kohno K, Seiki M, Hayakawa T, Welgus HG, Hori S and Kuwano M (1994) Expression of 72 kDa type IV collagenase and invasion activity of human glioma cells. Clin Exp Metas 12: 296-304
2. Albini A, Iwamoto Y, Kleinman HK, Martin GR, Aaronson SA, Kozlowski JM and McEwan RN (1987) A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res 47: 3239-3245
3. Barna BP, Estes ML and Jacobs BA (1990) Human astrocytes proliferate in response to tumor necrosis factor alpha. J Neuroimmunol 30: 239-243
4. Bergenheim AT, Gunnarsson PO, Edman K, Schoultz EV and Hariz M (1993) Uptake and retention of estramustine and presence of estramustine binding protein in malignant brain tumours in humans. Br J Cancer 67: 358-361
5. Borgenheim AT, Bjork P, Bergh J, von-Schoultz E, Svedberg H and Henriksson R (1994) Estramustine-binding and specific binding protein of the anti-mitotic compound estramustine in astrocytoma. Cancer Res 54: 4974-4979
6. Bernstein JJ, Laws ER, Levine KV, Wood LB, Tadvalkar G and Golgberg WJ (1991) C6 glioma-astrocytoma cells and fetal astrocyte migration into artificial basement membrane: A permissive substrate for neural tumors but not fetal astrocytes. Neurosurgery 28: 652-658
7. Birkedal-Hansen H, Moore WGI, Bodden MK, Windsor LJ, Birkendal-Hansen B, DeCarlo A and Engler JA (1993) Matrix metalloproteinases: A review. Crit Rev Oral Biol Med 4: 197-250
8. Bohn W, Roser K, Hohenberg H, Mannweiler K and Traub P (1993) Cytoskeleton architecture of C6 rat glioma cell subclones differing in intermediate filament protein expression. J Struct Biol 111: 48-58
9. Cameron RS and Rakic P (1994) Identification of membrane proteins that comprise the plasmalemmal junction between migrating neurons and radial glial cells. J Neurosci 14: 3139-3155
10. Coomber BL (1991) Cytoskeleton in TGF-beta- and bFGF-modulated endothelial monolayer repair. Exp Cell Res 194: 42-47
11. Dahllof B, Billstrom A, Cabral F and Hartley-Asp B (1993) Estramustine depolymerizes microtubules by binding to tubulin. Cancer Res 53: 4573-4581
12. Djakiew D, Pflug BR, Delsite R, Onoda M, Lynch JH, Arand R and Thompson EW (1993) Chemotaxis and chemokinesis of human prostate tumor cell lines in response to human prostate stromal cell secretory proteins containing a nerve growth factor-like protein. Cancer Res 53: 1416-1420
13. Hudes GR, Greenberg R, Krigel RL, Fox S, Scher R, Litwin S, Watts P, Speicher L, Tew K and Comis R (1992) Phase 2 study of Estramustine and Vinblastine, two microtubule inhibitors, in hormone-refractory prostate cancer. J Clin Oncol 10: 1754-1761
14. Janiak M, Hushmi HR and Janowska-Wieczorek A (1994) Use of the matrigel-based assay to measure the invasiveness of leukemic cells. Exp Hematol 22: 559-565
15. Lin CH and Forscher P (1993) Cytoskeleton remodeling during growth cone-target interactions. J Cell Biol 121: 1369-1383
16. Maria BL, Cumming R and Sukhu L (1992) Crown of microfilaments in the extending cytoplasmic processes of medulloblastoma glial progenitors. Ca J Neurol Sci 19: 23-33
17. Mohanam S, Sawaya R, McCutcheon I, Ali-Osman F, Boyd D and Rao JS (1993) Modulation in vitro of human glioblastoma cells by urokinase-type plasminogen activator receptor antibody. Cancer Res 53: 4143-4147
18. Moraga D, Rivas-Berrios A, Farías G, Wallin M and Maccioni RB (1992) Estramustine-phosphate binds to a tubulin binding domain on micro-tubule-associated proteins MAP-2 and tau. Biochim Biophys Acta 1121: 97-103
19. Nakagawa T, Kubota T, Kabuto M, Sato K, Kawano H, Hayakawa T and Okada Y (1994) Production of matrix metalloproteinases and tissue inhibitor of metalloproteinases-1 by human brain tumors. J Neurosurg 81: 69-77
20. Nakano A, Tani E, Miyazaki K, Yamamoto Y and Furuyama J (1995) Matrix metalloproteinases and tissue inhibitor of metalloproteinases in human gliomas. J Neurosurg 83: 298-307
21. Paulus W and Tonn JC (1994) Basement membrane invasion of glioma cells mediated by integrin receptors. J Neurosurg 80: 515-519
22. Pedersen PH, Ness GO, Engebraaten O, Bjerkvig R, Lillehaug JR and Laerum OD (1994) Heterogenous response to the growth factors [EGF, PDGF (bb), TGF-alpha, bFGF, IL-2] on glioma spheroid growth, migration, and invasion. Int J Cancer 56: 255-261
23. Piepmeier JM, Keefe DL, Weinstein MA, Yoshida D, Zielinski J, Lin TT, Chen Z and Naftolin F (1993) Estramustine and estrone analogs rapidly and reversibly inhibit deoxyribonucleic acid synthesis and alter morphology in cultured human glioblastoma cells. Neurosurgery 32: 422-431
24. Rao J, Steck PA, Mohanan S, Stetler-Stevenxon WG, Liotta LA and Sawaya R (1993) Elevated level of Mr 92,000 type IV collagenase in human brain tumors Cancer Res 53: 2208-2211
25. Reict A and Rucklidge GJ (1992) Invasion of brain tissue by primary glioma: Evidence for the involvement of urokinase-type plasminogen activator as an activator of type IV collagenase. Biochem Biophys Res Commun 186: 348-354
26. Rutberg M and Wallin M (1993) Estramustine induces disorganization of microtubules, perinuclear retraction of vimentin and endoplasmatic reticulum. and inhibits cell migration. Acta Histochem 95: 155-167
27. Ryu S, Gabel M, Khil MS, Lee YJ, Kim SH and Kim JH (1994) Estramustine: a novel radiation enhancer in human carcinoma cells. Int J Radiat Oncol Biol Phys 30: 99-104
28. Santell L, Marotti K, Bartfeld NS, Baynham P and Levin EG (1992) Disruption of microtubules inhibits the stimulation of tissue plasminogen activator expression and promotes plasminogen activator inhibitor type 1 expression in human endothelial cells. Exp Cell Res 201: 358-365
29. Speicher LA, Laing N, Barone LR, Robbins JD, Seamon KB and Tew KD (1994) Interaction of an estramustine photoaffinity analogue with cytoskeletal proteins in prostate carcinoma cells. Mol Pharmacol 46: 866-872
30. Stearns ME, Wang M and Sousa O (1991) Evidence that estramustine hinds MAP-1 A to inhibit type IV collagenase secretion. J Cell Sci 98: 55-63
31. Taylor CM, Weiss JB and Lye RH (1991) Raised levels of latent collagenase activating angiogenesis factor (ESAF) are present in actively growing human intracranial tumours. Br J Cancer 64: 164-168
32. Vaithilingam SI, McDonald W, Brown NK, Stroude E, Cook RA and DelMaestro RF (1992) Serum proteolytic activity during the growth of C6 astrocytoma. J Neurosurg 77: 595-600
33. von-Schoultz E, Lundblad D, Bergh J, Grankvist K and Henriksson R (1988) Estramustine binding protein and anti-proliferative effect of estramustine in human glioma cell lines. Br J Cancer 58: 326-329
34. von-Schoultz E, Gunnarsson P and Henriksson R (1989) Uptake, metabolism and antiproliferative effect of estramustine phosphate in human glioma cell lines. Anticancer Res 9: 1713-1716
35. von-Shoultz E, Lundgren E and Henriksson R (1990) Effects of estramustine and its constituents on human malignant glioma cells. Anticancer Res 10: 693-696
36. von-Shoultz E, Begenheim T, Grankvist K and Henriksson R (1991a) Estramustine binding protein in human brain-tumor tissue. J Neurosurg 74: 962-964
37. von-Shoultz E, Grankvist K, Gustavson H and Henriksson R (1991b) Effects of estramustine on DNA and cell membrane in malignant glioma cells. Acta Oncol 30: 719-723
38. Yoshida D, Cornell-Bell A and Piepmeier JM (1994a) Selective antimitotic effects of estramustine correlate with its antimicrotubule properties on glioblastoma and astrocytes. Neurosurgery 34: 863-868
39. Yoshida D, Piepmeier JM and Weinstein M (1994b) Estramustine sensitizes human glioblastoma cells to irradiation. Cancer Res 54: 1415-1417
40. Yoshida D, Piepmeier JM and Teramoto A (1996) In vitro inhibition of cell proliferation, viability, and invasiveness in U87MG human glioblastoma cells by estramustine phosphate. Neurosurgery 39: 360-366